Insmed Incorporated
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antiba…
Biotechnology
US, Bridgewater [HQ]
INSM/Financial Reporting
Income Statements
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.00 | 6.00 | 4.00 | - - | 11.00 | 11.00 | - - | - - | - - | 9.00 | 136.00 | 164.00 | 188.00 | 245.00 | 305.00 | |
|
EPS
|
9.30 | -0.49 | -2.56 | -1.56 | -1.60 | -1.84 | -2.02 | -2.85 | -2.89 | -4.22 | -3.01 | -3.01 | -3.88 | -3.91 | -5.34 | |
| Diluted in mil. | 9.30 | -0.49 | -2.56 | -1.56 | -1.60 | -1.84 | -2.02 | -2.85 | -2.89 | -4.22 | -3.01 | -3.01 | -3.88 | -3.91 | -5.34 | |
|
Profit
|
10.00 | 6.00 | 4.00 | -21.00 | -18.00 | -22.00 | -1.00 | -2.00 | -2.00 | 7.00 | 112.00 | 124.00 | 144.00 | 190.00 | 239.00 | |
| Gross Margin | 100.00 | 100.00 | 100.00 | - - | -157.77 | -191.61 | - - | - - | - - | 75.36 | 82.26 | 75.75 | 76.57 | 77.53 | 78.52 | |
| Pre Tax | 118.00 | -6.00 | -59.00 | -41.00 | -57.00 | -89.00 | -120.00 | -176.00 | -192.00 | -324.00 | -253.00 | -292.00 | -436.00 | -480.00 | -747.00 | |
| Profit Margin | 1,145.54 | -91.84 | -1,350.78 | - - | -498.21 | -778.97 | - - | - - | - - | -3,295.13 | -185.80 | -178.02 | -231.57 | -195.69 | -244.76 | |
| ETR | 0.40 | -1.23 | -15.38 | -1.84 | 2.13 | 11.63 | 1.64 | -0.06 | 0.14 | -0.06 | -0.31 | -0.48 | 0.40 | -0.29 | -0.34 | |
| Net | 118.00 | -6.00 | -59.00 | -41.00 | -56.00 | -79.00 | -118.00 | -176.00 | -192.00 | -324.00 | -254.00 | -294.00 | -434.00 | -481.00 | -749.00 | |
| Profit Margin | 1,140.94 | -92.96 | -1,350.78 | - - | -487.59 | -688.34 | - - | - - | - - | -3,297.17 | -186.37 | -178.87 | -230.63 | -196.26 | -245.59 | |
| EBITDA | -7.00 | -8.00 | -35.00 | -41.00 | -54.00 | -87.00 | -117.00 | -173.00 | -188.00 | -305.00 | -230.00 | -259.00 | -373.00 | -458.00 | -673.00 | |
| EBITDA Margin | -76.81 | -116.14 | -801.13 | - - | -472.77 | -758.47 | - - | - - | - - | -3,106.12 | -169.11 | -158.03 | -198.12 | -186.75 | -220.81 | |
| Operating Income | -8.00 | -8.00 | -61.00 | -42.00 | -55.00 | -87.00 | -117.00 | -173.00 | -188.00 | -307.00 | -235.00 | -265.00 | -367.00 | -478.00 | -709.00 | |
| Operating Margin | -83.62 | -116.92 | -1,397.31 | - - | -478.39 | -759.70 | - - | - - | - - | -3,124.94 | -172.38 | -161.32 | -195.14 | -194.87 | -232.51 | |
| Interest Income | - - | 1.00 | - - | - - | - - | - - | - - | - - | - - | - - | 9.00 | 1.00 | - - | 11.00 | 1.00 | |
| Loss | -19.00 | -15.00 | -40.00 | -42.00 | -66.00 | -87.00 | -117.00 | -173.00 | -188.00 | -317.00 | -371.00 | -429.00 | -556.00 | -723.00 | -986.00 | |
| Cost of Revenue | - - | - - | - - | -21.00 | -29.00 | -33.00 | -1.00 | -2.00 | -2.00 | -2.00 | -24.00 | -39.00 | -44.00 | -55.00 | -65.00 | |
|
Operating Expenses
|
-19.00 | -15.00 | -40.00 | -42.00 | -66.00 | -87.00 | -117.00 | -173.00 | -188.00 | -314.00 | -347.00 | -389.00 | -512.00 | -668.00 | -920.00 | |
| R&D | -9.00 | -4.00 | -27.00 | -29.00 | -44.00 | -56.00 | -74.00 | -122.00 | -109.00 | -145.00 | -131.00 | -181.00 | -272.00 | -397.00 | -571.00 | |
| G&A | - - | -10.00 | -12.00 | -12.00 | -22.00 | -31.00 | -43.00 | -50.00 | -79.00 | -168.00 | -210.00 | -203.00 | -234.00 | -244.00 | -344.00 | |
| SG&A | -9.00 | -10.00 | -12.00 | -12.00 | -22.00 | -31.00 | -43.00 | -50.00 | -79.00 | -168.00 | -210.00 | -203.00 | -234.00 | -265.00 | -344.00 | |
| S&M | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -20.00 | - - | |
| Depreciation and Amortization | - - | - - | - - | - - | - - | -1.00 | -1.00 | -2.00 | -2.00 | -4.00 | -10.00 | -14.00 | -14.00 | -10.00 | -10.00 | |
| Interest Expenses | - - | - - | - - | - - | -2.00 | -2.00 | -2.00 | -3.00 | -5.00 | -25.00 | -27.00 | -29.00 | -40.00 | -26.00 | -76.00 | |
| Other Expenses | -128.00 | -1.00 | -23.00 | -1.00 | - - | - - | - - | - - | -1.00 | -8.00 | -18.00 | -27.00 | -68.00 | -2.00 | -15.00 | |
|
WA Shares Outstanding
|
12.00 | 13.00 | 23.00 | 26.00 | 34.00 | 43.00 | 58.00 | 61.00 | 66.00 | 76.00 | 84.00 | 97.00 | 112.00 | 123.00 | 140.00 | |
| Diluted | 12.00 | 13.00 | 23.00 | 26.00 | 34.00 | 43.00 | 58.00 | 61.00 | 66.00 | 76.00 | 84.00 | 97.00 | 112.00 | 123.00 | 140.00 |